Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1982 Jun;36(3):933–942. doi: 10.1128/iai.36.3.933-942.1982

Electrophoretic analysis of polypeptides immune precipitated from cytomegalovirus-infected cell extracts by human sera.

L Pereira, M Hoffman, N Cremer
PMCID: PMC551420  PMID: 6284646

Abstract

Serodiagnosis of cytomegalovirus (CMV) infection by complement fixation tests depends on showing a fourfold rise in antibody titer from acute- to convalescent-phase sera. Freeze-thaw and glycine-extracted, infected cell culture antigens used for these tests give markedly different titers in reactions with the same sera. In this study, we characterized the CMV-infected cell polypeptides contained in freeze-thaw and glycine-extracted antigens and identified the proteins precipitated by 23 pairs of human acute and convalescent sera. Our results were as follows. First, freeze-thaw and glycine-extracted antigens prepared from infected cells radiolabeled with [35S]methionine and subjected to electrophoresis in sodium dodecyl sulfate-polyacrylamide gels yielded similar patterns, and the bulk of the label was contained in late structural proteins and glycoproteins. Glycine-extracted preparations contained a greater proportion of soluble 66,000- and 50,000-molecular-weight proteins than did freeze-thaw antigens. Second, convalescent sera precipitated proteins migrating with apparent molecular weights of 150,000, 130,000, 110,000, 96,000, 74,000, 66,000, 50,000, 34,000, 32,000, and 25,000. Of these the 130,000-, 110,000-, 96,000-, 66,000-, 50,000-, and 25,000-molecular-weight proteins comigrated with glucosamine-labeled polypeptides. Both immunoglobulin G and M antibodies in human sera precipitated these proteins from CMV-infected cell preparations. Implications of the results for serodiagnosis of CMV infections are discussed.

Full text

PDF
933

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Betts R. F., George S. D., Rundell R. B., Freeman R. B., Douglas R. G., Jr Comparative activity of immunofluorescent antibody and complement-fixing antibody in cytomegalovirus infection. J Clin Microbiol. 1976 Aug;4(2):151–156. doi: 10.1128/jcm.4.2.151-156.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Booth J. C., Hannington G., Tryhorn Y., Stern H. Cytomegalovirus complement-fixing IgM antibody. J Med Virol. 1980;5(3):183–193. doi: 10.1002/jmv.1890050303. [DOI] [PubMed] [Google Scholar]
  3. Cremer N. E., Hoffman M., Lennette E. H. Analysis of antibody assay methods and classes of viral antibodies in serodiagnosis of cytomegalovirus infection. J Clin Microbiol. 1978 Aug;8(2):153–159. doi: 10.1128/jcm.8.2.153-159.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cremer N. E., Schmidt N. J., Jensen F., Hoffman M., Oshiro L. S., Lennette E. H. Complement-fixing antibody in human sera reactive with viral and soluble antigens of cytomegalovirus. J Clin Microbiol. 1975 Mar;1(3):262–267. doi: 10.1128/jcm.1.3.262-267.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. DeMarchi J. M., Blankenship M. L., Brown G. D., Kaplan A. S. Size and complexity of human cytomegalovirus DNA. Virology. 1978 Sep;89(2):643–646. doi: 10.1016/0042-6822(78)90209-x. [DOI] [PubMed] [Google Scholar]
  6. Eberle R., Courtney R. J. Assay of type-specific and type-common antibodies to herpes simplex virus types 1 and 2 in human sera. Infect Immun. 1981 Mar;31(3):1062–1070. doi: 10.1128/iai.31.3.1062-1070.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fiala M., Honess R. W., Heiner D. C., Heine J. W., Jr, Murnane J., Wallace R., Guze L. B. Cytomegalovirus proteins. I. Polypeptides of virions and dense bodies. J Virol. 1976 Jul;19(1):243–254. doi: 10.1128/jvi.19.1.243-254.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Forghani B., Schmidt N. J., Lennette E. H. Antisera to human cytomegalovirus produced in hamsters: reactivity in radioimmunoassay and other antibody assay systems. Infect Immun. 1976 Nov;14(5):1184–1190. doi: 10.1128/iai.14.5.1184-1190.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gibson W. Structural and nonstructural proteins of strain Colburn cytomegalovirus. Virology. 1981 Jun;111(2):516–537. doi: 10.1016/0042-6822(81)90354-8. [DOI] [PubMed] [Google Scholar]
  10. Gupta P., St Jeor S., Rapp F. Comparison of the polypeptides of several strains of human cytomegalovirus. J Gen Virol. 1977 Mar;34(3):447–454. doi: 10.1099/0022-1317-34-3-447. [DOI] [PubMed] [Google Scholar]
  11. Huang E. S., Huong S. M., Tegtmeier G. E., Alford C. Cytomegalovirus: genetic variation of viral genomes. Ann N Y Acad Sci. 1980;354:332–346. doi: 10.1111/j.1749-6632.1980.tb27976.x. [DOI] [PubMed] [Google Scholar]
  12. Kampa D., Schmitz H., Doerr H. W., Luthardt T., Hillemanns H. G., Wurtele A. IgM antibodies to cytomegalovirus during pregnancy. Arch Virol. 1977;53(3):177–184. doi: 10.1007/BF01314662. [DOI] [PubMed] [Google Scholar]
  13. Kettering J. D., Schmidt N. J., Lennette E. H. Improved glycine-extracted complement-fixing antigen for human cytomegalovirus. J Clin Microbiol. 1977 Dec;6(6):647–649. doi: 10.1128/jcm.6.6.647-649.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kim K. S., Moon H. M., Sapienza V. J., Carp R. I. Complement-fixing antigen of human cytomegaloviruses. J Infect Dis. 1977 Feb;135(2):281–288. doi: 10.1093/infdis/135.2.281. [DOI] [PubMed] [Google Scholar]
  15. Kim K. S., Sapienza V. J., Carp R. I., Moon H. M. Analysis of structural polypeptides of purified human cytomegalovirus. J Virol. 1976 Dec;20(3):604–611. doi: 10.1128/jvi.20.3.604-611.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Pauls F. P., Dowdle W. R. A serologic study of herpesvirus hominis strains by microneutralization tests. J Immunol. 1967 May;98(5):941–947. [PubMed] [Google Scholar]
  17. Pereira L., Dondero D. V., Gallo D., Devlin V., Woodie J. D. Serological analysis of herpes simplex virus types 1 and 2 with monoclonal antibodies. Infect Immun. 1982 Jan;35(1):363–367. doi: 10.1128/iai.35.1.363-367.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Reynolds D. W., Stagno S., Stubbs K. G., Dahle A. J., Livingston M. M., Saxon S. S., Alford C. A. Inapparent congenital cytomegalovirus infection with elevated cord IgM levels. Casual relation with auditory and mental deficiency. N Engl J Med. 1974 Feb 7;290(6):291–296. doi: 10.1056/NEJM197402072900601. [DOI] [PubMed] [Google Scholar]
  19. Riggs J. L., Cremer N. E. Differentiation of cytomegalovirus antigens by their reactivity with various classes of human antibodies in the indirect fluorescent antibody test. J Clin Microbiol. 1980 Jan;11(1):88–93. doi: 10.1128/jcm.11.1.88-93.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Sarov I., Abady I. The morphogenesis of human cytomegalovirus. Isolation and polypeptide characterization of cytomegalovirions and dense bodies. Virology. 1975 Aug;66(2):464–473. doi: 10.1016/0042-6822(75)90218-4. [DOI] [PubMed] [Google Scholar]
  21. Stinski M. F. Human cytomegalovirus: glycoproteins associated with virions and dense bodies. J Virol. 1976 Aug;19(2):594–609. doi: 10.1128/jvi.19.2.594-609.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Stinski M. F., Mocarski E. S., Thomsen D. R., Urbanowski M. L. Membrane glycoproteins and antigens induced by human cytomegalovirus. J Gen Virol. 1979 Apr;43(1):119–129. doi: 10.1099/0022-1317-43-1-119. [DOI] [PubMed] [Google Scholar]
  23. Stinski M. F. Sequence of protein synthesis in cells infected by human cytomegalovirus: early and late virus-induced polypeptides. J Virol. 1978 Jun;26(3):686–701. doi: 10.1128/jvi.26.3.686-701.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Stinski M. F. Synthesis of proteins and glycoproteins in cells infected with human cytomegalovirus. J Virol. 1977 Sep;23(3):751–767. doi: 10.1128/jvi.23.3.751-767.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. The T. H., Langenhuysen M. M. Antibodies against membrane antigens of cytomegalovirus infected cells in sera of patients with a cytomegalovirus infection. Clin Exp Immunol. 1972 Aug;11(4):475–482. [PMC free article] [PubMed] [Google Scholar]
  26. Waner J. L. Partial characterization of a soluble antigen preparation from cells infected with human cytomegalovirus: properties of antisera prepared to the antigen. J Immunol. 1975 May;114(5):1454–1457. [PubMed] [Google Scholar]
  27. Waner J. L., Weller T. H. Analysis of antigenic diversity among human cytomegaloviruses by kinetic neutralization tests with high-titered rabbit antisera. Infect Immun. 1978 Jul;21(1):151–157. doi: 10.1128/iai.21.1.151-157.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Waner J. L., Weller T. H., Kevy S. V. Patterns of cytomegaloviral complement-fixing antibody activity: a longitudinal study of blood donors. J Infect Dis. 1973 May;127(5):538–543. doi: 10.1093/infdis/127.5.538. [DOI] [PubMed] [Google Scholar]
  29. Weller T. H. The cytomegaloviruses: ubiquitous agents with protean clinical manifestations. I. N Engl J Med. 1971 Jul 22;285(4):203–214. doi: 10.1056/NEJM197107222850406. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES